Co-administration of DAAs and DOACs Among Patients With HCV Co-administration of DAAs and DOACs Among Patients With HCV

The findings of this study offer reassurance that concurrent DAA and DOAC administration in patients with hepatitis C virus infection does not increase bleeding risk.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news